‘It’s Life-Threatening’—Dexcom G7 Users Say Glucose Monitor Is Failing Them

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Medical Device and Diagnostic Industry (MD+DI)

Dexcom Faces G6 Recall

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

Dexcom recalls G6 CGM app over software problem

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...
Fierce Biotech

Dexcom hit by FDA Class I recall for its continuous glucose monitoring system app

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...
Investing

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential

Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...
Barron's

DexCom Inc.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Drug Delivery Business

Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...